Owens & Minor Inc OMI
We take great care to ensure that the data presented and summarized in this overview for OWENS & MINOR INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding OMI
View all-
Coliseum Capital Management, LLC Rowayton, CT13.1MShares$36.7 Million7.64% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$32.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.96MShares$16.7 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.51MShares$9.82 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.26MShares$9.13 Million0.01% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA3.21MShares$8.98 Million0.0% of portfolio
-
Invenomic Capital Management LP Boston, MA2.75MShares$7.7 Million0.66% of portfolio
-
Paradigm Capital Management Inc2.61MShares$7.31 Million0.56% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.32MShares$6.5 Million0.01% of portfolio
-
State Street Corp Boston, MA1.96MShares$5.5 Million0.0% of portfolio
Latest Institutional Activity in OMI
Top Purchases
Top Sells
About OMI
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.
Insider Transactions at OMI
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 19
2025
|
Andrew G Long EVP, CEO P&HS |
SELL
Bona fide gift
|
Direct |
47,908
-18.29%
|
-
|
|
Sep 23
2025
|
Jonathan A Leon EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,265
-1.91%
|
$21,325
$5.4 P/Share
|
|
Aug 14
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
492,852
+3.63%
|
$2,464,260
$5.31 P/Share
|
|
Aug 13
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
325,000
+2.51%
|
$1,625,000
$5.46 P/Share
|
|
Aug 12
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
720,000
+5.54%
|
$3,600,000
$5.15 P/Share
|
|
Jun 03
2025
|
Jennifer A Stone EVP, CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,764
-4.97%
|
$34,584
$6.35 P/Share
|
|
May 19
2025
|
Heath H Galloway EVP,General Counsel & CorpSecy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,768
-1.49%
|
$12,376
$7.38 P/Share
|
|
May 15
2025
|
Robert J Henkel Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,914
+27.19%
|
-
|
|
May 15
2025
|
Teresa L. Kline Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,914
+34.82%
|
-
|
|
May 15
2025
|
Carissa Rollins Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,914
+34.91%
|
-
|
|
May 15
2025
|
Mark A Beck Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,914
+41.92%
|
-
|
|
May 15
2025
|
Rita Johnson Mills Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,914
+34.82%
|
-
|
|
May 15
2025
|
Stephen W Klemash Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,914
+32.87%
|
-
|
|
May 15
2025
|
Kenneth Gardner Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,914
+34.49%
|
-
|
|
May 15
2025
|
Michael Wayne Lowry SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
1,533
-1.24%
|
$10,731
$7.0 P/Share
|
|
May 15
2025
|
Edward A Pesicka President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
35,208
-2.97%
|
$246,456
$7.0 P/Share
|
|
May 15
2025
|
Snehashish Sarkar |
SELL
Payment of exercise price or tax liability
|
Direct |
4,336
-3.84%
|
$30,352
$7.0 P/Share
|
|
May 15
2025
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
SELL
Payment of exercise price or tax liability
|
Direct |
13,394
-5.41%
|
$93,758
$7.0 P/Share
|
|
May 15
2025
|
Heath H Galloway EVP,General Counsel & CorpSecy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,315
-1.1%
|
$9,205
$7.0 P/Share
|
|
May 15
2025
|
Jonathan A Leon EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,641
-1.17%
|
$18,487
$7.0 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 1.26M shares |
|---|---|
| Open market or private purchase | 5.37M shares |
| Payment of exercise price or tax liability | 122K shares |
|---|---|
| Bona fide gift | 47.9K shares |